Intrinsic Value of S&P & Nasdaq Contact Us

MPX International Corporation MPXOF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
60/100
1/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

MPX International Corporation (MPXOF) generated $0.00 in operating cash flow for fiscal year 2023. After capital expenditures of $0.00, free cash flow was $0.00.

Criteria supported by this page:

  • HEALTH (100/100, Fail) — weak cash flow raises concerns about debt servicing
  • MOAT (50/100, Partial) — cash flow generation is present but not at levels indicating a wide moat

Overall SharesGrow Score: 55/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
60/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
N/A
No coverage
PAST
0/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
Proven by this page
~
MOAT
50/100
Proven by this page
GROWTH
90/100
→ Income
INCOME
N/A
No coverage
MPX International Corporation Cash Flow History
Metric TTM FY2023 FY2022 FY2021 FY2020
Operating Cash Flow $0.00$0.00$0.00$-8.13M$-12.18M
Capital Expenditure $0.00$0.00$0.00$-5.26M$-4.24M
Free Cash Flow $0.00$0.00$0.00$-13.39M$-16.42M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message